PMC Links for Books (Select 5497686) - PMC

Select item 102403981.

Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial

Julien Mazieres, Paul K. Paik, Marina C. Garassino, Xiuning Le, Hiroshi Sakai, Remi Veillon, Egbert F. Smit, Alexis B. Cortot, Jo Raskin, Santiago Viteri, Yi-Long Wu, James C. H. Yang, Myung-Ju Ahn, Rui Ma, Jun Zhao, Aurora O’Brate, Karin Berghoff, Rolf Bruns, Gordon Otto, Andreas Johne, Enriqueta Felip, Michael Thomas

JAMA Oncol. 2023 Sep; 9(9): 1260–1266. Published online 2023 Jun 4. doi: 10.1001/jamaoncol.2023.1962

Correction in:: JAMA Oncol. 2023 Sep; 9(9): 1300.

PMCID:: PMC10240398

Abstract Article

Select item 101838052.

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, Jianying Zhou, Dong-Wan Kim, Ross Andrew Soo, Ying Cheng, Shun Lu, Sang Won Shin, James Chih-Hsin Yang, Yiping Zhang, Jun Zhao, Karin Berghoff, Rolf Bruns, Andreas Johne, Yi-Long Wu

Clin Cancer Res. 2023 May 15; 29(10): 1879–1886. Published online 2023 Mar 27. doi: 10.1158/1078-0432.CCR-22-3318

PMCID:: PMC10183805

Abstract Article PDF–1.7M

Select item 100689103.

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management

Remi Veillon, Hiroshi Sakai, Xiuning Le, Enriqueta Felip, Alexis B. Cortot, Egbert F. Smit, Keunchil Park, Frank Griesinger, Christian Britschgi, Yi-Long Wu, Barbara Melosky, Shobhit Baijal, Gilberto de Castro, Jr, Michaela Sedova, Karin Berghoff, Gordon Otto, Paul K. Paik

Clin Lung Cancer. Author manuscript; available in PMC 2023 Apr 3.

Published in final edited form as: Clin Lung Cancer. 2022 Jun; 23(4): 320–332. Published online 2022 Mar 17. doi: 10.1016/j.cllc.2022.03.002

PMCID:: PMC10068910

Abstract Article PDF–1.2M

Select item 95702664.

Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report

Liang-Wei Tseng, John Wen-Cheng Chang, Chiao-En Wu

Int J Mol Sci. 2022 Oct; 23(19): 11809. Published online 2022 Oct 5. doi: 10.3390/ijms231911809

PMCID:: PMC9570266

Abstract Article PDF–528K

Select item 84226795.

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

Paul K. Paik, Enriqueta Felip, Remi Veillon, Hiroshi Sakai, Alexis B. Cortot, Marina C. Garassino, Julien Mazieres, Santiago Viteri, Helene Senellart, Jan Van Meerbeeck, Jo Raskin, Niels Reinmuth, Pierfranco Conte, Dariusz Kowalski, Byoung Chul Cho, Jyoti D. Patel, Leora Horn, Frank Griesinger, Ji-Youn Han, Young-Chul Kim, Gee-Chen Chang, Chen-Liang Tsai, James C.-H. Yang, Yuh-Min Chen, Egbert F. Smit, Anthonie J. van der Wekken, Terufumi Kato, Dilafruz Juraeva, Christopher Stroh, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, John V. Heymach, Xiuning Le

N Engl J Med. Author manuscript; available in PMC 2021 Sep 7.

Published in final edited form as: N Engl J Med. 2020 Sep 3; 383(10): 931–943. Published online 2020 May 29. doi: 10.1056/NEJMoa2004407

PMCID:: PMC8422679

Abstract Article PDF–1.1M

Select item 82924116.

Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression

Baek-Yeol Ryoo, Ann-Li Cheng, Zhenggang Ren, Tae-You Kim, Hongming Pan, Kun-Ming Rau, Hye Jin Choi, Joong-Won Park, Jee Hyun Kim, Chia Jui Yen, Ho Yeong Lim, Dongli Zhou, Josef Straub, Juergen Scheele, Karin Berghoff, Shukui Qin

Br J Cancer. 2021 Jul 20; 125(2): 200–208. Published online 2021 May 10. doi: 10.1038/s41416-021-01380-3

PMCID:: PMC8292411

Abstract Article PDF–536K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity